Successful treatment with weekly paclitaxel in a patient with recurrent endornetrial cancer. A case report

The best treatment for recurrent endometrial cancer is still uncertain, although weekly paclitaxel has shown some promise in the management of this disease. In this report we present a patient with recurrent endometrial cancer treated with weekly paclitaxel. Serial power Doppler angiography was used to assess the effects of therapy. The response was good, suggesting that recurrent endometrial cancer may be successfully treated with weekly paclitaxel and effectively monitored with power Doppler angiography.

Recurrent endometrial cancer; Weekly paclitaxel

[1] Elit L., Hirte H.: "Current status and future innovations of hormonal agents, chemotherapy and investigational agents in endometrial cancer". Cun: Opin. Obstet. Gynecol., 2002, 14, 67.

[2] Anderson H., Horvath G., Mellqvist L., Westberg R.:'Taxol given weekly in advanced previously treated ovarian carcinoma: a pilot study". Int. J. Gynecol. Cancer, 1997, 7, 262.

[3] Klassen U., Wilke H., Strumberg D., Eberhardt W., Korn M., Seeber S.: "Phase l study with a weekly I h infusion of paclitaxel in heavily pretreated patients with metastatic breast and ovarian cancer". Eur. J. Cancer, 1996, 32, 547.

[4] Eisenhauer E.A., ten Bokkel Huinink W.W., Swenerton K.D., Gianni L., Myles J., van der Burg M.E. et al.: "European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer high-dose versus low-dose and long versus short infusion". J. Clin. Oncol., 1994, 12, 2654.

[5] T savaris N.B., Kosrnas C.: "Risk of severe acute hypersensitivity reactions after rapid paclitaxel infusion of less than 1-h duration" Cancer Chemother. Pharmacol., 1998, 42, 509

[6] Ota S., Sugiyama T., Ushijima K., Kornai K., Fujiyoshi K., Hirai N. et al.: "Successful treatment of two patients with recurrent endornetrial cancer by weekly paclitaxel". Cancer lett., 2000, 160, 9.